Lee D, Jin X, Choi P, Cui Y, Che X, Lee S
Exp Mol Med. 2025; 57(2):323-334.
PMID: 39894822
PMC: 11873240.
DOI: 10.1038/s12276-025-01390-8.
Ahn S, Kim E, Kim M, Shin S, Kwon J
J Dent Sci. 2025; 20(1):212-219.
PMID: 39873034
PMC: 11762959.
DOI: 10.1016/j.jds.2024.08.005.
Ji H, Pan Q, Cao R, Li Y, Yang Y, Chen S
Heliyon. 2024; 10(3):e25601.
PMID: 38333852
PMC: 10850749.
DOI: 10.1016/j.heliyon.2024.e25601.
Korani S, Khalesi N, Korani M, Jamialahmadi T, Sahebkar A
Bone Rep. 2024; 20:101740.
PMID: 38304620
PMC: 10831168.
DOI: 10.1016/j.bonr.2024.101740.
Lei Z, Wang Q, Jiang Q, Liu H, Xu L, Kang H
Cancers (Basel). 2024; 16(2).
PMID: 38254792
PMC: 10813535.
DOI: 10.3390/cancers16020302.
Biochanin A abrogates osteoclastogenesis in type 2 diabetic osteoporosis via regulating ROS/MAPK signaling pathway based on integrating molecular docking and experimental validation.
He Q, Yang J, Chen W, Pan Z, Chen B, Zeng J
BMC Complement Med Ther. 2024; 24(1):24.
PMID: 38191438
PMC: 10773052.
DOI: 10.1186/s12906-023-04332-x.
Extracellular Vesicles from Human Adipose Tissue-Derived Mesenchymal Stem Cells Suppress RANKL-Induced Osteoclast Differentiation via miR122-5p.
Choi J, Sung S, Kang K, Lee S, Sung M, Park W
Biochem Genet. 2023; 62(4):2830-2852.
PMID: 38017286
DOI: 10.1007/s10528-023-10569-5.
Ginsenoside Rg2 inhibits osteoclastogenesis by downregulating the NFATc1, c-Fos, and MAPK pathways.
Lee S, Park S, Kim J, Kim N, Lee J
BMB Rep. 2023; 56(10):551-556.
PMID: 37605614
PMC: 10618073.
Inhibition of Osteoclast Differentiation and Promotion of Osteogenic Formation by Mycelium.
Son T, Kim S, Shin H, Kim D, Huh J, Ryoo R
J Microbiol Biotechnol. 2023; 33(9):1197-1205.
PMID: 37317624
PMC: 10580891.
DOI: 10.4014/jmb.2304.04048.
A novel microRNA-182/Interleukin-8 regulatory axis controls osteolytic bone metastasis of lung cancer.
Zhao M, Zhang L, Sun Z, Qiao L, Yang T, Ren Y
Cell Death Dis. 2023; 14(5):298.
PMID: 37127752
PMC: 10151336.
DOI: 10.1038/s41419-023-05819-8.
spp.: Secondary Metabolites, Pharmacological Activities, and Mechanisms.
Hadisaputri Y, Nurhaniefah A, Sukmara S, Zuhrotun A, Hendriani R, Sopyan I
Metabolites. 2023; 13(2).
PMID: 36837836
PMC: 9964934.
DOI: 10.3390/metabo13020217.
Changes in Metabolism and Mitochondrial Bioenergetics during Polyethylene-Induced Osteoclastogenesis.
Mohamad Hazir N, Mohamad Yahaya N, Zawawi M, Damanhuri H, Mohamed N, Alias E
Int J Mol Sci. 2022; 23(15).
PMID: 35955464
PMC: 9368566.
DOI: 10.3390/ijms23158331.
Regulation of osteoclast-mediated bone resorption by microRNA.
Ji L, Li X, He S, Chen S
Cell Mol Life Sci. 2022; 79(6):287.
PMID: 35536437
PMC: 11071904.
DOI: 10.1007/s00018-022-04298-y.
Erucin inhibits osteoclast formation via suppressing cell-cell fusion molecule DC-STAMP without influencing mineralization by osteoblasts.
Takagi T, Inoue H, Fujii S, Takahashi N, Uehara M
BMC Res Notes. 2022; 15(1):105.
PMID: 35296341
PMC: 8925049.
DOI: 10.1186/s13104-022-05988-3.
Current Aspects on the Pathophysiology of Bone Metabolic Defects during Progression of Scoliosis in Neurofibromatosis Type 1.
Kaspiris A, Savvidou O, Vasiliadis E, Hadjimichael A, Melissaridou D, Iliopoulou-Kosmadaki S
J Clin Med. 2022; 11(2).
PMID: 35054138
PMC: 8781800.
DOI: 10.3390/jcm11020444.
Extracellular vesicles derived from the periodontal pathogen Filifactor alocis induce systemic bone loss through Toll-like receptor 2.
Kim H, Song M, Gho Y, Kim H, Choi B
J Extracell Vesicles. 2021; 10(12):e12157.
PMID: 34648247
PMC: 8516034.
DOI: 10.1002/jev2.12157.
Downregulation of miR-21 gene expression by CRE-Ter to modulate osteoclastogenesis: De Novo mechanism.
Pengjam Y, Prajantasen T, Tonwong N, Panichayupakaranant P
Biochem Biophys Rep. 2021; 26:101002.
PMID: 33997317
PMC: 8099503.
DOI: 10.1016/j.bbrep.2021.101002.
Biological Evaluation and Transcriptomic Analysis of Corylin as an Inhibitor of Osteoclast Differentiation.
Yu A, Xiao J, Zhao S, Kong X, Kwan K, Zhong-Yu Zheng B
Int J Mol Sci. 2021; 22(7).
PMID: 33805517
PMC: 8036378.
DOI: 10.3390/ijms22073540.
Fucoxanthin Suppresses Osteoclastogenesis via Modulation of MAP Kinase and Nrf2 Signaling.
Ha Y, Choi Y, Oh Y, Kang E, Khang G, Park Y
Mar Drugs. 2021; 19(3).
PMID: 33673704
PMC: 7997314.
DOI: 10.3390/md19030132.
Kalkitoxin Reduces Osteoclast Formation and Resorption and Protects against Inflammatory Bone Loss.
Li L, Yang M, Shrestha S, Kim H, Gerwick W, Soh Y
Int J Mol Sci. 2021; 22(5).
PMID: 33669069
PMC: 7956546.
DOI: 10.3390/ijms22052303.